Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal diffuse large B-cell lymphomas (DLBCLs). However, the microRNAs profiles of primary cutaneous large B-cell lymphomas (PCLBCLs) are not yet described. Its two main subtypes, i.e., primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL-LT) and primary cutaneous follicle center lymphoma (PCFCL) are characterized by an activated B-cell (ABC)-genotype and a germinal center B-cell (GCB)-genotype, respectively. We performed high-throughput sequencing analysis on frozen tumor biopsies from 19 cases of PCFCL and PCLBCL-LT to establish microRNA profiles. Cluster analysis of the complete microRNome could not distinguish between the two subtypes, but...
Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We explore the ...
Primary cutaneous large B-cell lymphomas (PCLBCL) represent a diagnostic challenge because they are ...
Abstract Despite being considered a single disease, Diffuse Large B Cell Lymphoma (DLBCL) presents w...
<div><p>Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal...
Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal diffuse...
MicroRNAs are naturally occurring small RNA species that regulate gene expression and are frequently...
Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly 40% of al...
a<p>higher expression in subgroup of PCLBCL.</p><p>PCFCL: primary cutaneous follicle center lymphoma...
Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly 40% of al...
Diffuse large B-cell lymphoma (DLBCL) can present as de novo or can arise through the transformation...
We studied the global miRNA expression in diffuse large B-cell lymphoma (DLBCL; n=79), Burkitt lymph...
AbstractMicroRNAs (miRNAs) are small endogenous RNA molecules that regulate gene expression at the p...
Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We explore the ...
The oncogenic microRNA (miR) 17–92 cluster has a causative role in the lymphomagenesis of nodal B-ce...
: We analyzed the clinicopathological, cytogenetic, and molecular features of 18 primary cutaneous d...
Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We explore the ...
Primary cutaneous large B-cell lymphomas (PCLBCL) represent a diagnostic challenge because they are ...
Abstract Despite being considered a single disease, Diffuse Large B Cell Lymphoma (DLBCL) presents w...
<div><p>Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal...
Aberrant expression of microRNAs is widely accepted to be pathogenetically involved in nodal diffuse...
MicroRNAs are naturally occurring small RNA species that regulate gene expression and are frequently...
Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly 40% of al...
a<p>higher expression in subgroup of PCLBCL.</p><p>PCFCL: primary cutaneous follicle center lymphoma...
Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly 40% of al...
Diffuse large B-cell lymphoma (DLBCL) can present as de novo or can arise through the transformation...
We studied the global miRNA expression in diffuse large B-cell lymphoma (DLBCL; n=79), Burkitt lymph...
AbstractMicroRNAs (miRNAs) are small endogenous RNA molecules that regulate gene expression at the p...
Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We explore the ...
The oncogenic microRNA (miR) 17–92 cluster has a causative role in the lymphomagenesis of nodal B-ce...
: We analyzed the clinicopathological, cytogenetic, and molecular features of 18 primary cutaneous d...
Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We explore the ...
Primary cutaneous large B-cell lymphomas (PCLBCL) represent a diagnostic challenge because they are ...
Abstract Despite being considered a single disease, Diffuse Large B Cell Lymphoma (DLBCL) presents w...